Watching, but not waiting: vascular neurology perspective on the disparate regulatory pathways for stroke.

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMC 4198506)

Published in J Neurointerv Surg on April 15, 2014

Authors

Sunil A Sheth1, Raul G Nogueira2, Ali Reza Noorian1, David S Liebeskind1

Author Affiliations

1: Department of Neurology, University of California Los Angeles, Los Angeles, California, USA.
2: Department of Neurology, Emory University, Atlanta, Georgia, USA.

Articles citing this

Stroke is ascendant: is it time for TICI to be more than just a score? J Neurointerv Surg (2015) 0.75

Articles cited by this

Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med (2009) 17.17

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78

A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med (2013) 9.97

Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet (2012) 8.76

Endovascular treatment for acute ischemic stroke. N Engl J Med (2013) 8.45

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09

Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet (2012) 7.89

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet (2009) 7.64

Bivalirudin for patients with acute coronary syndromes. N Engl J Med (2006) 5.49

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet (2001) 4.78

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet (1999) 4.36

A comparison of reteplase with alteplase for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. N Engl J Med (1997) 3.61

A comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction. The Continuous Infusion versus Double-Bolus Administration of Alteplase (COBALT) Investigators. N Engl J Med (1997) 2.43

Endovascular treatment for acute ischemic stroke--still unproven. N Engl J Med (2013) 1.68

Influence of etiology of atrial fibrillation on incidence of systemic embolism. Am J Cardiol (1977) 1.23

Relationship of stroke to other cardiovascular disease. Circulation (1968) 1.13